NAD(P)H:Quinone Oxidoreductase 1 (NQO1) P187S Polymorphism and Prostate Cancer Risk in Caucasians

Contribution of NAD(P)H Quinone Oxidoreductase 1 (NQO1) Pro187Ser Polymorphism and Risk of Colorectal Adenoma and Colorectal Cancer in Caucasians: A Meta-analysis

(2012) Jing Chen et al.   ARCHIVES OF MEDICAL RESEARCH

Antioxidants for prostate cancer chemoprevention: Challenges and opportunities

(2012) Dinesh Thapa et al.   BIOCHEMICAL PHARMACOLOGY

Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease

(2012) Amanda Crawford et al.   GENE

Reactive Oxygen Species (ROS)––Induced genetic and epigenetic alterations in human carcinogenesis

(2011) Dominique Ziech et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector

(2010) Albena T. Dinkova-Kostova et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis

(2010) Weiguang Yuan et al.   BREAST CANCER RESEARCH AND TREATMENT

Dietary Glucosinolate Intake, Polymorphisms in Selected Biotransformation Enzymes, and Risk of Prostate Cancer

(2010) A. Steinbrecher et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Prostate Cancer Radiosensitization through Poly(ADP-Ribose) Polymerase-1 Hyperactivation

(2010) Y. Dong et al.   CANCER RESEARCH

Constitutive expression of bioactivating enzymes in normal human prostate suggests a capability to activate pro-carcinogens to DNA-damaging metabolites

(2010) Francis L. Martin et al.   PROSTATE

Oxidative stress in prostate cancer

(2009) Lakshmipathi Khandrika et al.   CANCER LETTERS